title: Lenalidomide and second malignancies in myeloma patients.
authors: School of Cancer Sciences, University of Birmingham, Birmingham, B9 5SS, UK; Department of Haematology, Birmingham Heartlands Hospital, Birmingham, B9 5SS, UK. Electronic address: guy.pratt@heartofengland.nhs.uk.
authors: Guy
authors: G
authors: Pratt
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D006801:Humans; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000188:drug therapy*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide; D000077269:Lenalidomide